Posted November 10, 2017
GlaxoSmithKline will have another blockbuster vaccine as the cost for Shingrix is estimated to be $280 for two doses and it will be recommended for every adult over the age of 50. The article in the NYT states, “…clinical trials showed {Shingrix} to be about 98% effective for one year and 85% effective at preventing shingles for three years.” Since one in three adult Americans will contact shingles at some point in their lives, a vaccine that is effective at preventing shingles would be good thing. Read more.